Investor Ideas #Potcasts; #Cannabis News
and Stocks on the Move; TSX: $WEED.TO,
TSX: $ACB.TO, TSX: $APH.TO
July 5th Potcast sponsored
by Lexaria Bioscience Corp. (CSE: $LXX.C) (OTC: $LXRP) a #Cannabis company with
a new disruptive drug delivery platform: DehydraTECH
Pt. Roberts, WA; Delta, BC –July 5, 2018
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its “potcast’
site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this news in full at http://www.investorideas.com/news/2018/cannabis/07056Potcasts-TSX-WEED-ACB-APH.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another Investorideas.com potcast ;
looking at cannabis news, stocks to watch as well as insights from thought
leaders and experts.
Today’s potcast was sponsored by Kelowna based Lexaria Bioscience Corp trading on the CSE under symbol LXX and on
the OTC as LXRP. Lexaria has developed a new disruptive
drug delivery platform: DehydraTECH The Company’s patented technology changes
the way Active Pharmaceutical Ingredients (“APIs”) enter the body orally:
1) Masks unwanted tastes – eliminates the need for sugar-filled edibles.
2) Reduces time of onset – effects are felt within 15-20 min vs. 60-120
min.
3) Avoids first-pass liver metabolism
4) Increases bio-absorption by 5-10X
The Company’s DehydraTECH™ technology is patent-protected for multiple
APIs: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Non-steroidal
anti-inflammatory drugs (NSAIDs) such as ibuprofen, Nicotine and Fat soluble
vitamins.
Today’s podcast features announcements from Canopy Growth Corporation (TSX:
WEED and the NYSE: CGC) , Aurora Cannabis Inc. (TSX: ACB and OTCQB: ACBFF) and Aphria Inc. (TSX : APH and USOTC: APHQF).
Canopy
Growth Corporation introduced its Latin American affiliate Canopy LATAM
Corporation ("Canopy LATAM"), a wholly owned and controlled
subsidiary of Canopy Growth Corporation. Through Canopy LATAM, the Company has
acquired Spectrum Cannabis Colombia S.A.S. ("Spectrum Cannabis
Colombia"), which previously operated as Colombian Cannabis S.A.S.
("Colombian Cannabis"), expanding the Company's focus on the emerging
medical cannabis market of Latin America.
This
announcement represents a leap forward in the Company's growth strategy for its
industry leading Spectrum Cannabis brand. As a member of the Canopy Growth
family, Canopy LATAM will focus on advancing medical cannabis and capturing
market share across the region, home to more than 600 million people, as
individual nations modernize their medical cannabis legislation.
Canopy
Growth Corporation also announced that it has closed its previously announced
transaction to acquire the remaining 33% stake of BC Tweed Joint Venture Inc.
("BC Tweed"). The consolidation of the two largest federally
licensed cannabis facilities in the world into full Canopy Growth ownership
cements the Company's commitment to shareholder value through scale production.
"Our BC
Tweed operations have allowed us to pursue and finalize large recreational
supply contracts across Canada," said Mark Zekulin, President and Co-CEO,
Canopy Growth. "Construction and retrofitting work continues at both
greenhouse sites to continue on an aggressive pace towards licensing all 3
million sq. ft. of production."
Finally,
Canopy Growth Corporation also announced the completion of a major supply
agreement with the Alberta Gaming, Liquor & Cannabis Commission
("AGLC") to supply the province with premium cannabis products in a
variety of forms including whole-flower, oil, and Softgel capsules.
Under the
terms of the agreement, the largest of its kind in Canada, Canopy Growth will
supply Alberta with over 15,000 kilograms of cannabis products to support the
first six months of the province's adult use recreational cannabis market set
to open on October 17, 2018. Inventory will be replenished by the Company as
requested and the AGLC reserves the right to extend the agreement for up to two
additional years in 12-month increments. Should the need arise, Canopy Growth
is prepared to go beyond the minimum supply commitment to ensure the AGLC has
sufficient product to meet market demand.
Combining
the Company's supply agreements with six provinces and one territory including
New Brunswick, Newfoundland & Labrador, Prince Edward Island, Quebec,
Yukon, recently announced Manitoba and now Alberta, Canopy Growth is committed
to supply these markets on an annualized basis with up to 61,500 kilograms of
cannabis products in the first year of legal sales with varying incremental
multi-year obligations by province. Supply agreements are supported by a
national production platform which includes a state-of-the-art indoor
production facility located just outside Edmonton, Alberta. Initially announced
in June 2017, the production site ensures that Albertans are accessing Tweed and
other Canopy Growth-affiliated products from a company proudly investing in the
province.
Aurora
Cannabis Inc. announced that it has also entered into an agreement with the
Alberta Gaming, Liquor & Cannabis Commission ("AGLC") to supply
high-quality cannabis products for the adult consumer use market in the
province. Consequently, Aurora will initially allocate up to 25,000 kg of
product for the first 6 months of sales to this market.
Aurora's
three facilities in Alberta - Aurora Sky, Mountain, and Sun - with a combined
funded production capacity of more than 250,000 kg per year, uniquely position
Aurora to provide a reliable, high-quality supply of cannabis to the Province.
Through this agreement, Aurora, which is the leader in the medical cannabis market
in Alberta, will play an important role in ensuring sufficient product is
available to the adult consumer market in the province.
Aphria Inc.
today announced that it has signed a Supply Agreement with the Alberta Gaming,
Liquor & Cannabis Commission as well, to provide a portfolio of
high-quality cannabis and cannabis-derivative products for sale in Alberta's
adult-use market.
Under the
terms of the Agreement, the AGLC has placed an opening order of 870 kg to be
supplied from across the full portfolio of Aphria's adult-use brands and
products, including dried flower, pre-rolls and cannabis oils. Once additional
product categories, such as vapes and edibles, are authorized under the
Cannabis Act, it is anticipated that they will also be made for sale throughout
the province, further enhancing the Company's assortment of offerings in this
market.
Aphria Inc.
also announced that it has successfully completed the divestiture of the
Company's ownership interest in Copperstate Farms, LLC and Copperstate Farms Investors,
LLC previously announced on February 2, 2018. Aphria's original investment
was approximately $11.1 million ($8.2 million USD). Aphria received $20
million as part of the divestiture, realizing a gain of approximately $8.8
million on the sale.
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment.
Lexaria Bioscience Corp. has developed and
out-licenses its disruptive delivery technology that promotes healthier
ingestion methods, lower overall dosing and higher effectiveness of lipophilic
active molecules. Lexaria has multiple patents pending in over 40 countries
around the world and has patents granted in the USA and in Australia for
utilization of its DehydraTECHTM delivery technology. Lexaria's technology
provides increases in intestinal absorption rates; more rapid delivery to the
bloodstream; and important taste-masking benefits, for orally administered
bioactive molecules including cannabinoids, vitamins, non-steroidal
anti-inflammatory drugs (NSAIDs), nicotine and other molecules. www.lexariabioscience.com
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Google Play Music, Stitcher and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Investorideas.com
cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the
Investorideas.com news and stock directory pages, a cannabis investor group on Linkedin.com
, the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure Lexaria
Bioscience Corp. ( CSE: LXX) (OTC: LXRP) is a media sponsor of the podcast
starting July 5 2018 more info http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment